Track how companies discuss tariffs and trade policies in their earnings calls, and understand their impact across different industries and regions.
with our intellectual property being domiciled in the US and our low cost of goods, we are insulated from potential biopharmaceutical tariffs and do not anticipate any material impact on our business.
the existing and potentially higher tariffs, making owning existing assets even more attractive.
Concern over tariffs has been a major source of uncertainty. Granite like all companies, is not immune to the direct and indirect impacts of tariffs.
Overall, we are seeing caution in the spending pattern more so than a complete freeze.
We estimate a tariff cost impact of $175 million to $250 million annually.
I recognize there's a lot of uncertainty at the moment related to tariffs and taxes.
Through prudent operations and planning, we were able to effectively neutralize exposure to any potential tariffs this year.
We prioritize being close to our customers. And over the last several years, we’ve worked to establish a localized supply chain and cost-effective manufacturing footprint.
we believe the terms and conditions in our contracts limit our exposure to direct cost increases associated with the currently implemented tariffs.
Tariffs are creating significant demand uncertainty and increased cost for us.